Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Broadwind sees Q2 revenue $45M-$50M, consensus $42.73M » 07:27
05/07/21
05/07
07:27
05/07/21
07:27
BWEN

Broadwind

$4.62 /

-0.12 (-2.53%)

"We expect an…

"We expect an increase in shipments in the second quarter, particularly within our Heavy Fabrication and Gearing segments. We expect second quarter 2021 revenue to be in a range of $45 to $50 million and adjusted EBITDA to be in a range of $4.5 to $5.0 million, after including approximately 3.0 million of additional ERC benefits," said CEO Eric Blashford.

ShowHide Related Items >><<
BWEN Broadwind
$4.62 /

-0.12 (-2.53%)

04/12/21
Broadwind management to meet virtually with Roth Capital
01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
BWEN Broadwind
$4.62 /

-0.12 (-2.53%)

BWEN Broadwind
$4.62 /

-0.12 (-2.53%)

BWEN Broadwind
$4.62 /

-0.12 (-2.53%)

Earnings
Broadwind reports Q1 EPS (7c), consensus (17c) » 07:27
05/07/21
05/07
07:27
05/07/21
07:27
BWEN

Broadwind

$4.62 /

-0.12 (-2.53%)

Reports Q1 revenue…

Reports Q1 revenue $32.7M, consensus $35.55M. Wind tower section orders up 103% year-over-year. "Although our first quarter results were adversely impacted by a combination of adverse weather conditions, a shift in the timing of a customer order and pandemic-related supply chain constraints, our business recovered during April, supported by new customer orders and improved plant utilization. We are seeing a broad market recovery that will drive growth in our industrial businesses in the second half of this year," stated Eric Blashford, President and CEO of Broadwind. "Wind tower orders more than doubled on a year-over-year basis in the first quarter, as original equipment manufacturer customers began to fill production slots for the second half of 2021," continued Blashford. "To date, we have booked approximately 60% of our optimal wind tower production capacity for the full-year 2021. First quarter gearing orders improved sequentially, supported by increased demand within both industrial and energy markets, consistent with our expectations for a gradual recovery in the Gearing segment during 2021. Following the one-year extension of the renewable electricity production tax credit announced in late 2020, together with other recent policy actions intended to accelerate private investment in new wind energy installations, expectations around medium-term onshore wind capacity additions continue to improve. Currently, we anticipate that approximately 35 GW of new onshore wind capacity will be added to the U.S. market by year-end 2023," continued Blashford. "In the last two years, project developers have installed more wind power capacity than any other energy generating technology, as the levelized, unsubsidized cost of wind energy continues to decline. In March the Biden Administration announced a transformational plan to deploy 30 GW of new offshore wind energy capacity by 2030, including provisions for the construction of new facilities to support the production of wind turbine components, including those produced by Broadwind," stated Blashford. "We believe this plan and related policy considerations reflect a long-term, bipartisan commitment to achieving a net zero economy, one where our long-term customer OEM relationships, technical expertise and strategic asset base position us to support the ongoing clean energy transition. At the end of the first quarter, we had more than $21 million in total cash and availability under our line of credit to support operations and growth opportunities," continued Blashford.

ShowHide Related Items >><<
BWEN Broadwind
$4.62 /

-0.12 (-2.53%)

04/12/21
Broadwind management to meet virtually with Roth Capital
01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
BWEN Broadwind
$4.62 /

-0.12 (-2.53%)

BWEN Broadwind
$4.62 /

-0.12 (-2.53%)

BWEN Broadwind
$4.62 /

-0.12 (-2.53%)

Over a week ago
Conference/Events
Broadwind management to meet virtually with Roth Capital » 04:55
04/12/21
04/12
04:55
04/12/21
04:55
BWEN

Broadwind

$5.70 /

-0.25 (-4.20%)

Virtual Meeting to be…

Virtual Meeting to be held on April 12 hosted by Roth Capital.

ShowHide Related Items >><<
BWEN Broadwind
$5.70 /

-0.25 (-4.20%)

04/12/21
Broadwind management to meet virtually with Roth Capital
01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
BWEN Broadwind
$5.70 /

-0.25 (-4.20%)

BWEN Broadwind
$5.70 /

-0.25 (-4.20%)

BWEN Broadwind
$5.70 /

-0.25 (-4.20%)

Recommendations
Broadwind management to meet virtually with Roth Capital » 04:55
04/12/21
04/12
04:55
04/12/21
04:55
BWEN

Broadwind

$5.70 /

-0.25 (-4.20%)

Virtual Meeting to be…

Virtual Meeting to be held on April 12 hosted by Roth Capital.

ShowHide Related Items >><<
BWEN Broadwind
$5.70 /

-0.25 (-4.20%)

01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
BWEN Broadwind
$5.70 /

-0.25 (-4.20%)

BWEN Broadwind
$5.70 /

-0.25 (-4.20%)

BWEN Broadwind
$5.70 /

-0.25 (-4.20%)

Conference/Events
Broadwind management to meet virtually with Roth Capital » 07:34
04/09/21
04/09
07:34
04/09/21
07:34
BWEN

Broadwind

$5.95 /

+0.02 (+0.34%)

Virtual Meeting to be…

Virtual Meeting to be held on April 12 hosted by Roth Capital.

ShowHide Related Items >><<
BWEN Broadwind
$5.95 /

+0.02 (+0.34%)

01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
BWEN Broadwind
$5.95 /

+0.02 (+0.34%)

BWEN Broadwind
$5.95 /

+0.02 (+0.34%)

BWEN Broadwind
$5.95 /

+0.02 (+0.34%)

Over a month ago
Conference/Events
Broadwind management to meet virtually with Roth Capital » 11:44
04/05/21
04/05
11:44
04/05/21
11:44
BWEN

Broadwind

$5.95 /

-0.22 (-3.57%)

Virtual Meeting to be…

Virtual Meeting to be held on April 5 hosted by Roth Capital.

ShowHide Related Items >><<
BWEN Broadwind
$5.95 /

-0.22 (-3.57%)

01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
BWEN Broadwind
$5.95 /

-0.22 (-3.57%)

BWEN Broadwind
$5.95 /

-0.22 (-3.57%)

BWEN Broadwind
$5.95 /

-0.22 (-3.57%)

Options
new option listings on March 24th » 08:30
03/24/21
03/24
08:30
03/24/21
08:30
ACET

Adicet Bio

$14.12 /

-0.39 (-2.69%)

, ALUS

Alussa Energy Acquisition

$10.15 /

-0.115 (-1.12%)

, ANIX

Anixa Biosciences

$4.80 /

-1.975 (-29.17%)

, ATHA

Athira Pharma

$18.52 /

-0.46 (-2.42%)

, BBAX

JPMorgan BetaBuilders Developed Asia ex-Japan ETF

$28.04 /

-0.38085 (-1.34%)

, BBJP

JPMorgan BetaBuilders Japan ETF

$28.74 /

-0.44 (-1.51%)

, BWEN

Broadwind

$5.25 /

-0.33 (-5.91%)

, CBLI

Cleveland BioLabs

$5.66 /

-0.48 (-7.82%)

, EQ

Equillium

$7.47 /

-0.64 (-7.89%)

, FBIO

Fortress Biotech

$3.94 /

-0.23 (-5.52%)

, FDMT

4D Molecular

$43.32 /

-1.24 (-2.78%)

, FLOT

iShares Floating Rate Bond ETF

$50.80 /

+ (+0.00%)

, HSKA

Heska

$172.40 /

-4.79 (-2.70%)

, IMAB

I-MAB

$48.85 /

-4.56 (-8.54%)

, JPST

JPS Industries

$50.75 /

+0.005 (+0.01%)

, LIZI

Lizhi

$8.61 /

-0.76 (-8.11%)

, OLMA

Olema Oncology

$37.68 /

+0.01 (+0.03%)

, PLRX

Pliant Therapeutics

$38.25 /

+0.17 (+0.45%)

, RAAS

Cloopen

$19.65 /

-0.165 (-0.83%)

, RPTX

Repare Therapeutics

$28.44 /

-2.4 (-7.78%)

, SCR

Score Media

$27.19 /

-0.04 (-0.15%)

, SLGG

Super League Gaming

$8.40 /

-1.02 (-10.83%)

, TFII

TFI International

$72.00 /

-2.82 (-3.77%)

, ZNTL

Zentalis

$42.41 /

-5.28 (-11.07%)

New option listings for…

New option listings for March 24th include Adicet Bio (ACET), Alussa Energy Acquisition Corp (Class A Stock) (ALUS), Anixa Biosciences Inc (ANIX), Athira Pharma Inc (ATHA), JPMorgan BetaBuilders Developed Asiaex Japan ETF (BBAX), JPMorgan BetaBuilders International Equity (BBIN), JPMorgan BetaBuilders Japan ETF (BBJP), Broadwind Energy (BWEN), Cleveland BioLabs (CBLI), Global X (COPX), Global X SuperDividend US (DIV), Equillium Inc (EQ), Fortress Biotech (FBIO), 4D Molecular Therapeutics Inc (FDMT), iShares Floating Rate (FLOT), Heska (HSKA), I MAB (ADS) (IMAB), Jpmorgan Equity Premium Income ETF (JEPI), JPMorgan Ultra-Short Income ETF (JPST), LIZHI Inc (ADS) (LIZI), Olema Pharmaceuticals Inc (OLMA), Pliant Therapeutics Inc (PLRX), Cloopen Group Holding Limited (Class A ADS) (RAAS), First Trust NASDAQ Rising Dividend Achievers (RDVY), Repare Therapeutics Inc (RPTX), Score Media and Gaming Inc (Class A Stock) (SCR), Super League Gaming Inc (SLGG), TFI International Inc (TFII), and Zentalis Pharmaceuticals Inc (ZNTL).

ShowHide Related Items >><<
ZNTL Zentalis
$42.41 /

-5.28 (-11.07%)

TFII TFI International
$72.00 /

-2.82 (-3.77%)

SLGG Super League Gaming
$8.40 /

-1.02 (-10.83%)

RAAS Cloopen
$19.65 /

-0.165 (-0.83%)

PLRX Pliant Therapeutics
$38.25 /

+0.17 (+0.45%)

LIZI Lizhi
$8.61 /

-0.76 (-8.11%)

IMAB I-MAB
$48.85 /

-4.56 (-8.54%)

HSKA Heska
$172.40 /

-4.79 (-2.70%)

FDMT 4D Molecular
$43.32 /

-1.24 (-2.78%)

FBIO Fortress Biotech
$3.94 /

-0.23 (-5.52%)

EQ Equillium
$7.47 /

-0.64 (-7.89%)

CBLI Cleveland BioLabs
$5.66 /

-0.48 (-7.82%)

ATHA Athira Pharma
$18.52 /

-0.46 (-2.42%)

ANIX Anixa Biosciences
$4.80 /

-1.975 (-29.17%)

ALUS Alussa Energy Acquisition
$10.15 /

-0.115 (-1.12%)

ACET Adicet Bio
$14.12 /

-0.39 (-2.69%)

ACET Adicet Bio
$14.12 /

-0.39 (-2.69%)

11/04/20
Fly Intel: Top five analyst initiations
11/04/20 B. Riley
B. Riley sees 200% potential upside in 'attractive value play' Adicet Bio
11/04/20 B. Riley
Adicet Bio initiated with a Buy at B. Riley Securities
10/27/20 JMP Securities
Adicet Bio initiated with an Outperform at JMP Securities
ALUS Alussa Energy Acquisition
$10.15 /

-0.115 (-1.12%)

ANIX Anixa Biosciences
$4.80 /

-1.975 (-29.17%)

ATHA Athira Pharma
$18.52 /

-0.46 (-2.42%)

10/13/20 Jefferies
Athira Pharma initiated with a Buy at Jefferies
10/13/20 JMP Securities
Athira Pharma initiated with an Outperform at JMP Securities
10/13/20 Stifel
Athira Pharma initiated with a Buy at Stifel
10/13/20 Goldman Sachs
Athira Pharma initiated with a Buy at Goldman Sachs
BBAX JPMorgan BetaBuilders Developed Asia ex-Japan ETF
$28.04 /

-0.38085 (-1.34%)

BBJP JPMorgan BetaBuilders Japan ETF
$28.74 /

-0.44 (-1.51%)

BWEN Broadwind
$5.25 /

-0.33 (-5.91%)

01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
CBLI Cleveland BioLabs
$5.66 /

-0.48 (-7.82%)

EQ Equillium
$7.47 /

-0.64 (-7.89%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
FBIO Fortress Biotech
$3.94 /

-0.23 (-5.52%)

02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
12/14/20 Benchmark
Decision looms on Fortress' Caelum after partner Alexion bought, says Benchmark
10/13/20 B. Riley
Fortress Biotech weakness on Avenue CRL overblown, says B. Riley Securities
10/12/20 H.C. Wainwright
H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL
FDMT 4D Molecular
$43.32 /

-1.24 (-2.78%)

01/05/21 Evercore ISI
4D Molecular initiated with an Outperform at Evercore ISI
01/05/21 BofA
4D Molecular initiated with a Buy at BofA
01/05/21 Goldman Sachs
4D Molecular initiated with a Neutral at Goldman Sachs
FLOT iShares Floating Rate Bond ETF
$50.80 /

+ (+0.00%)

HSKA Heska
$172.40 /

-4.79 (-2.70%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
IMAB I-MAB
$48.85 /

-4.56 (-8.54%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
JPST JPS Industries
$50.75 /

+0.005 (+0.01%)

LIZI Lizhi
$8.61 /

-0.76 (-8.11%)

OLMA Olema Oncology
$37.68 /

+0.01 (+0.03%)

12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
12/14/20 Canaccord
Olema Pharmaceuticals initiated with a Buy at Canaccord
12/14/20 Cowen
Olema Pharmaceuticals initiated with an Outperform at Cowen
PLRX Pliant Therapeutics
$38.25 /

+0.17 (+0.45%)

08/11/20 Piper Sandler
Pliant Therapeutics' approach to fibrotic diseases best in industry, says Piper
06/29/20 Needham
Pliant Therapeutics initiated with a Buy at Needham
06/29/20 Cowen
Pliant Therapeutics initiated with an Outperform at Cowen
06/29/20 Citi
Pliant Therapeutics initiated with a Buy at Citi
RAAS Cloopen
$19.65 /

-0.165 (-0.83%)

03/09/21 Citi
Cloopen initiated with a Buy, $27 price target at Citi
03/08/21 Citi
Cloopen initiated with a Buy at Citi
03/06/21 Goldman Sachs
Cloopen initiated with a Neutral at Goldman Sachs
RPTX Repare Therapeutics
$28.44 /

-2.4 (-7.78%)

03/01/21 Berenberg
Repare Therapeutics initiated with a Buy at Berenberg
12/29/20 Northland
Northland ups Repare Therapeutics price target to $42, calls a Top Pick for 2021
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Northland
Repare Therapeutics initiated with an Outperform at Northland
SCR Score Media
$27.19 /

-0.04 (-0.15%)

03/23/21 Credit Suisse
Score Media initiated with an Outperform at Credit Suisse
03/22/21 Macquarie
Score Media initiated with an Outperform at Macquarie
SLGG Super League Gaming
$8.40 /

-1.02 (-10.83%)

03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
02/09/21 Alliance Global Partners
Super League downgraded on 'rich' valuation at Alliance Global
02/09/21 Alliance Global Partners
Super League Gaming downgraded to Neutral from Buy at Alliance Global Partners
TFII TFI International
$72.00 /

-2.82 (-3.77%)

02/12/21 UBS
TFI International downgraded to Neutral from Buy at UBS
02/10/21 National Bank
TFI International price target raised to C$110 from C$103 at National Bank
02/10/21 Desjardins
TFI International price target raised to C$108 from C$102 at Desjardins
02/10/21 TD Securities
TFI International price target raised to C$115 from C$110 at TD Securities
ZNTL Zentalis
$42.41 /

-5.28 (-11.07%)

01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
09/28/20 Cantor Fitzgerald
Zentalis initiated with an Overweight at Cantor Fitzgerald
08/27/20 H.C. Wainwright
Zentalis initiated with a Buy at H.C. Wainwright
ZNTL Zentalis
$42.41 /

-5.28 (-11.07%)

RPTX Repare Therapeutics
$28.44 /

-2.4 (-7.78%)

PLRX Pliant Therapeutics
$38.25 /

+0.17 (+0.45%)

OLMA Olema Oncology
$37.68 /

+0.01 (+0.03%)

HSKA Heska
$172.40 /

-4.79 (-2.70%)

FBIO Fortress Biotech
$3.94 /

-0.23 (-5.52%)

EQ Equillium
$7.47 /

-0.64 (-7.89%)

BWEN Broadwind
$5.25 /

-0.33 (-5.91%)

ATHA Athira Pharma
$18.52 /

-0.46 (-2.42%)

  • 03
    Mar
  • 25
    Feb
  • 10
    Feb
  • 09
    Feb
  • 09
    Feb
  • 21
    Jan
  • 13
    Jan
  • 11
    Dec
  • 19
    Nov
  • 24
    Sep
  • 18
    Sep
  • 27
    Aug
  • 14
    Aug
  • 13
    Aug
  • 30
    Jul
  • 19
    Jun
  • 03
    Jun
  • 03
    Apr
SCR Score Media
$27.19 /

-0.04 (-0.15%)

LIZI Lizhi
$8.61 /

-0.76 (-8.11%)

SCR Score Media
$27.19 /

-0.04 (-0.15%)

RAAS Cloopen
$19.65 /

-0.165 (-0.83%)

OLMA Olema Oncology
$37.68 /

+0.01 (+0.03%)

LIZI Lizhi
$8.61 /

-0.76 (-8.11%)

FDMT 4D Molecular
$43.32 /

-1.24 (-2.78%)

EQ Equillium
$7.47 /

-0.64 (-7.89%)

CBLI Cleveland BioLabs
$5.66 /

-0.48 (-7.82%)

BWEN Broadwind
$5.25 /

-0.33 (-5.91%)

ATHA Athira Pharma
$18.52 /

-0.46 (-2.42%)

ACET Adicet Bio
$14.12 /

-0.39 (-2.69%)

BBAX JPMorgan BetaBuilders Developed Asia ex-Japan ETF
$28.04 /

-0.38085 (-1.34%)

Earnings
Broadwind reports Q4 EPS (12c), consensus (12c) » 07:17
02/25/21
02/25
07:17
02/25/21
07:17
BWEN

Broadwind

$8.47 /

+0.21 (+2.54%)

Reports Q4 revenue…

Reports Q4 revenue $40.3M, consensus $40.81M. Fourth quarter results were impacted by a delay in the delivery of a tower order to a new wind turbine customer, lower gearing demand and pandemic-related supply chain disruptions. Both Heavy Fabrications and Gearing Segment revenue declined on a year-over-year basis in the fourth quarter, partially offset by growth in the Industrial Solutions segment.

ShowHide Related Items >><<
BWEN Broadwind
$8.47 /

+0.21 (+2.54%)

BWEN Broadwind
$8.47 /

+0.21 (+2.54%)

01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
BWEN Broadwind
$8.47 /

+0.21 (+2.54%)

BWEN Broadwind
$8.47 /

+0.21 (+2.54%)

Over a quarter ago
Recommendations
Broadwind price target raised to $12.50 from $4 at Roth Capital » 07:57
01/26/21
01/26
07:57
01/26/21
07:57
BWEN

Broadwind

$11.24 /

+2.27 (+25.31%)

Roth Capital analyst…

Roth Capital analyst Justin Clare raised the firm's price target on Broadwind to $12.50 from $4 and keeps a Buy rating on the shares. The analyst notes that Broadwind preannounced downside Q4 results on a delayed wind tower order and lower Gearing revenue due to pandemic-related supply chain disruptions. While Broadwind's near-term financials are being impacted by the pandemic, the long-term prospects continue to improve, he contends. Clare believes the PTC extension will support higher onshore U.S. wind demand through 2025, while the 30% ITC for offshore wind projects that begin construction prior to 2026 serves as another source of upside.

ShowHide Related Items >><<
BWEN Broadwind
$11.24 /

+2.27 (+25.31%)

BWEN Broadwind
$11.24 /

+2.27 (+25.31%)

01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
09/09/20 Johnson Rice
Broadwind initiated with a Buy at Johnson Rice
BWEN Broadwind
$11.24 /

+2.27 (+25.31%)

BWEN Broadwind
$11.24 /

+2.27 (+25.31%)

Downgrade
Broadwind downgraded to Neutral from Buy at H.C. Wainwright » 06:04
01/26/21
01/26
06:04
01/26/21
06:04
BWEN

Broadwind

$11.24 /

+2.27 (+25.31%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Amit Dayal downgraded Broadwind to Neutral from Buy without a price target. The analyst sees potential weakness in the company's near-term performance due to delays in tower delivery to a wind turbine customer and weakness in the gearing segment.

ShowHide Related Items >><<
BWEN Broadwind
$11.24 /

+2.27 (+25.31%)

BWEN Broadwind
$11.24 /

+2.27 (+25.31%)

12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
09/09/20 Johnson Rice
Broadwind initiated with a Buy at Johnson Rice
07/22/20 H.C. Wainwright
Wind 'a big beneficiary' in NY renewable energy expansion, says H.C. Wainwright
BWEN Broadwind
$11.24 /

+2.27 (+25.31%)

BWEN Broadwind
$11.24 /

+2.27 (+25.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.